Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Embedding equity in clinical research governance

Inclusion by Design is a governance blueprint for auditable representation across trials and data infrastructures

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Cherubini, A. et al. Eur. Heart J. 44, 3201–3210 (2023).

    Article  Google Scholar 

  2. Krumholz, H. M. et al. BMJ 380, e0725 (2023).

    Google Scholar 

  3. EMA. EMA Regulatory Science to 2025. Strategic Reflection (2020).

  4. EC. Proposal for a Regulation on the European Health Data Space (COM(2022) 197 final) (2022).

  5. EU. Artificial Intelligence Act (Regulation (EU) 2024/1689) (2024).

  6. CIOMS. International Ethical Guidelines for Health-related Research Involving Humans (2016).

  7. Retzer, A. et al. Nat. Med. 29, 3259–3267 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Bowleg, L. Am. J. Public Health 102, 1267–1273 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  9. EU. Regulation (EU) no 536/2014 on Clinical Trials on Medicinal Products for Human Use (2014).

  10. MRCT Center. Diversity, Equity, and Inclusion in Clinical Research Toolkit v1.1. (2021).

  11. Obermeyer, Z., Powers, B., Vogeli, C. & Mullainathan, S. Science 366, 447–453 (2019).

    Article  CAS  PubMed  Google Scholar 

  12. FACILITATE Consortium. White Paper on the Return of Individual Participant Data by Design (2024).

  13. Blom, J. M. C. et al. Front. Pharmacol. 16, 1570899 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  14. WHO. WHA 75.8: Strengthening Clinical Trials to Provide High-quality Evidence on Health Interventions (2022).

  15. US FDA. Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies (2024).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Johanna M. C. Blom.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Blom, J.M.C., Staunton, C., Tascedda, S. et al. Embedding equity in clinical research governance. Nat Med (2026). https://doi.org/10.1038/s41591-026-04232-w

Download citation

  • Published:

  • Version of record:

  • DOI: https://doi.org/10.1038/s41591-026-04232-w

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing